Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Techniques to assess response to treatment and the management of bone disease in myeloma

Prof Meletios Dimopoulos, Prof Pieter Sonneveld, Prof Heinz Ludwig
Techniques to assess response to treatment and the management of bone disease in myeloma ( Prof Meletios Dimopoulos, Prof Pieter Sonneveld, Prof Heinz Ludwig )
24 May 2011

Blood test for lung cancer in never-smokers

Dr Charlie Birse - Celera Corporation, California, USA
Blood test for lung cancer in never-smokers ( Dr Charlie Birse - Celera Corporation, California, USA )
21 Apr 2011

Biomarker target for lung cancer chemoprevention

Prof Paul Bunn - University of Colorado, Denver, USA
Biomarker target for lung cancer chemoprevention ( Prof Paul Bunn - University of Colorado, Denver, USA )
19 Apr 2011

Serum test could identify lung cancer in people who never smoked

Dr Charlie Birse - Celera Corporation, California, USA
Serum test could identify lung cancer in people who never smoked ( Dr Charlie Birse - Celera Corporation, California, USA )
15 Apr 2011

Protein test detects early-stage, asbestos-related pulmonary cancer

Dr Harvey Pass - NYU Langone Medical Center, New York, USA
Protein test detects early-stage, asbestos-related pulmonary cancer ( Dr Harvey Pass - NYU Langone Medical Center, New York, USA )
15 Apr 2011

Multidisciplinary mass gathering and celebration of European basic, translational and clinical studies (5/5)

Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO)
Multidisciplinary mass gathering and celebration of European basic, translational and clinical studies (5/5) ( Michael Baumann - ECCO President & Congress Chair; David Kerr - ESMO President; Anne-Lise Børresen Dale - Scientific Co-Chair (ECCO) )
11 Apr 2011

Role of predictive markers in personalised cancer treatment

Prof Ken O'Byrne - St James's Hospital, Dublin, Ireland
Role of predictive markers in personalised cancer treatment ( Prof Ken O'Byrne - St James's Hospital, Dublin, Ireland )
11 Mar 2011

Significance of the ALK Marker in non-smoker lung cancer patients

Prof Ping Yang - Mayo Clinic, Rochester, USA
Significance of the ALK Marker in non-smoker lung cancer patients ( Prof Ping Yang - Mayo Clinic, Rochester, USA )
11 Mar 2011

Translational science centre

Prof Nic Jones - MCRC and Paterson Institute, Manchester, UK
Translational science centre ( Prof Nic Jones - MCRC and Paterson Institute, Manchester, UK )
28 Dec 2010

The European Academy of Cancer Sciences

Prof Alexander Eggermont and Prof Anton Berns
The European Academy of Cancer Sciences ( Prof Alexander Eggermont and Prof Anton Berns )
21 Dec 2010

Identification of progenitor cells within the pituitary gland

Dr Karine Rizzoti - MRC National Institute of Medical Research, UK
Identification of progenitor cells within the pituitary gland ( Dr Karine Rizzoti - MRC National Institute of Medical Research, UK )
18 Nov 2010

Investigating mTOR as a treatment for neuroendocrine tumours

Dr Simona Grozinsky-Glasberg - Rabin Medical Center, Israel and Tel Aviv University, Israel
Investigating mTOR as a treatment for neuroendocrine tumours ( Dr Simona Grozinsky-Glasberg - Rabin Medical Center, Israel and Tel Aviv University, Israel )
1 Nov 2010